Dr. Srinath Kadimi, MD

Dr. Kadimi practices at Yale Medicine in New Haven, Connecticut.

Dr. Kadimi's NPI, 1730144734, was assigned on April 20, 2006. Dr. Kadimi graduated from Guntur Medical College NTR in 1985. Dr. Kadimi holds Connecticut license 038525.

Dr. Kadimi's primary practice is Yale Medicine, at 50 Division St, New Haven, CT 06511 in South Central Ct County. The practice phone is (203) 785-2140.

Dr. Kadimi's primary practice is Yale Medicine in New Haven, Connecticut. Dr. Kadimi is also affiliated with Yale New Haven Hospital. The medical group on file is Yale Health. Dmand AI also links Dr. Kadimi to 5 more hospitals, 14 medical groups and 8 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kadimi practices, 14 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Kadimi's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dmand AI has Dr. Kadimi's licenses on file in 6 states: Connecticut, Arkansas, Mississippi, Pennsylvania, South Carolina and Tennessee.

CMS data shows 7,210 Medicare services from Dr. Kadimi across 5 procedure codes in 2024, for 503 Medicare patients. Medicare paid $90,803 for them. Every service was in an office.

CMS counts 503 Medicare patients who saw Dr. Kadimi in 2024. The largest group is 75 to 84, with 222 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 23% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kadimi's median patient age at 72, with 61% women.

In 2024, Dr. Kadimi wrote 3,136 Medicare Part D claims for 525 patients. 96% of them were for generic drugs. CMS names the drug for 2,807 of them, across 47 drugs with 11 or more claims each, at $105,310 in total drug cost. In 2023, CMS named 2,739 claims across 55 drugs.

Dr. Kadimi accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kadimi as offering telehealth.

Dmand AI links 2 papers to Dr. Kadimi, published from 2011 to 2022. Dr. Kadimi's most frequent co-authors are Perminder J S Bhatia, MD, Daniel J. Burdick, MD and Michael Joseph Camilleri, MD.

Dmand AI links Dr. Kadimi to 4 clinical trials, 4 of them phase 2 studies. Conditions studied include Aggression, Alzheimer Disease and Cognitive Dysfunction.

CMS Open Payments shows 892 general payments to Dr. Kadimi from 58 drug and device companies from 2016 to 2023. Speaker and faculty fees make up the largest share, 64% of the total. Abbvie Inc. paid the most, $16,854. It also lists 15 research payments totaling $2,290 from 2016 to 2018.

Dr. Kadimi graduated from Guntur Medical College NTR in 1985.